Inhibiting autophagy selectively prunes dysfunctional tumor vessels and optimizes the tumor immune microenvironment
Authors:
Open Access
- 1 January 2025
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 15 (1) , 258-276
Abstract
Dysfunctional tumor vasculature, hypoxia, and an immunosuppressive microenvironment are significant barriers to effective cancer therapy. Autophagy, which is critical for maintaining cellular homeostasis and apoptosis resistance, is primarily triggered by hypoxia and nutrient deprivation, conditions prevalent in dysfunctional tumor vessels due to poor circulation. However, the role of autophagy in dysfunctional tumor endothelial cells and its impact on treatment and the tumor microenvironment (TME) remain poorly understood.Keywords
This publication has 29 references indexed in Scilit:
- Overexpression of ULK1 Represents a Potential Diagnostic Marker for Clear Cell Renal Carcinoma and the Antitumor Effects of SBI-0206965EBioMedicine, 2018
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challengesNature Reviews Clinical Oncology, 2018
- Defining the role of the tumor vasculature in antitumor immunity and immunotherapyCell Death & Disease, 2018
- Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug deliveryCancer Letters, 2017
- Tumor location impacts immune response in mouse models of colon cancerOncotarget, 2017
- Intraoperative intravital microscopy permits the study of human tumour vesselsNature Communications, 2016
- Granzyme B secretion by human memory CD4 T cells is less strictly regulated compared to memory CD8 T cellsBMC Immunology, 2014
- Tumor Vessel Normalization by Chloroquine Independent of AutophagyCancer Cell, 2014
- Participation of DNA repair in the response to 5-fluorouracilCellular and Molecular Life Sciences, 2008
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971